Auliac JB, Monnet I, Bizieux A, Greillier L, et al. Multicenter phase II trial of nintedanib plus docetaxel in second-line treatment in advanced non-squamous non-small cell lung cancer patients refractory to first-line platin-based chemotherapy (REFRACT GFPC 02-15 study). Lung Cancer 2021;161:122-127.
PMID: 34583220